Former Abbott Drug Unit Issues Second Synthroid Recall

Abbott's former pharmaceutical unit, now spun off as AbbVie, recently recalled more than 28,520 bottles of the thyroid-hormone replacement therapy Synthroid over a dose mix-up, marking the second recall of the drug in six months.
Source: WSJ.com: Health - Category: Pharmaceuticals Tags: PAID Source Type: news